tetano
Editor, Senior Moderator
Cureus
. 2022 Mar 14;14(3):e23162.
doi: 10.7759/cureus.23162. eCollection 2022 Mar.
A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
Zaki Al-Yafeai[SUP] 1 [/SUP], Benjamin Joesph M Horn[SUP] 1 [/SUP], William Terraccaine[SUP] 2 [/SUP], Alvin Jose[SUP] 3 [/SUP], Prathik Krishnan[SUP] 4 [/SUP]
Affiliations
Abstract
In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3).
Keywords: anca associated vasculitis; canca/proteinase 3-positive granulomatosis with polyangiitis; covid-19; covid-19 vaccine; granulomatosis with polyangiitis (gpa); pr3-anca; pr3-positive granulomatosis with polyangiitis; wegener's granulomatosis.
. 2022 Mar 14;14(3):e23162.
doi: 10.7759/cureus.23162. eCollection 2022 Mar.
A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
Zaki Al-Yafeai[SUP] 1 [/SUP], Benjamin Joesph M Horn[SUP] 1 [/SUP], William Terraccaine[SUP] 2 [/SUP], Alvin Jose[SUP] 3 [/SUP], Prathik Krishnan[SUP] 4 [/SUP]
Affiliations
- PMID: 35444915
- PMCID: PMC9010006
- DOI: 10.7759/cureus.23162
Abstract
In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3).
Keywords: anca associated vasculitis; canca/proteinase 3-positive granulomatosis with polyangiitis; covid-19; covid-19 vaccine; granulomatosis with polyangiitis (gpa); pr3-anca; pr3-positive granulomatosis with polyangiitis; wegener's granulomatosis.